4,544
Views
70
CrossRef citations to date
0
Altmetric
Review

Trial watch: Dendritic cell-based anticancer immunotherapy

ORCID Icon, , , , , & ORCID Icon show all
Article: e1328341 | Received 05 May 2017, Accepted 05 May 2017, Published online: 28 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now
Shu Ichimiya, Akiko Fujimura, Muneyuki Masuda, Shogo Masuda, Ryuji Yasumatsu, Masayo Umebayashi, Hiroto Tanaka, Norihiro Koya, Shinichiro Nakagawa, Poh Yin Yew, Sachiko Yoshimura, Hideya Onishi, Masafumi Nakamura, Yusuke Nakamura & Takashi Morisaki. (2022) Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma. Immunological Investigations 51:5, pages 1498-1514.
Read now
Nasim Ebrahimi, Maryam Akbari, Masoud Ghanaatian, Parichehr Roozbahani moghaddam, Samaneh Adelian, Marziyeh Borjian Boroujeni, Elnaz Yazdani, Amirhossein Ahmadi & Michael R. Hamblin. (2022) Development of neoantigens: from identification in cancer cells to application in cancer vaccines. Expert Review of Vaccines 21:7, pages 941-955.
Read now
Takashi Morisaki, Tetsuro Hikichi, Hideya Onishi, Takafumi Morisaki, Makoto Kubo, Tatsuya Hirano, Sachiko Yoshimura, Kazuma Kiyotani & Yusuke Nakamura. (2021) Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites. Immunological Investigations 50:5, pages 562-579.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, Yuta Mishima, Noriko Watanabe, Takashi Yamada, Satoru Senju, Shin Kaneko, Alimjan Idiris, Tetsuya Nakatsura, Hideki Ohdan & Yasushi Uemura. (2020) Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Nadia Mensali, Amalie Grenov, Niladri Bhusan Pati, Pierre Dillard, Marit Renée Myhre, Gustav Gaudernack, Gunnar Kvalheim, Else Marit Inderberg, Oddmund Bakke & Sébastien Wälchli. (2019) Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity. OncoImmunology 8:3.
Read now
Shuichi Hanada, Tomoko Tsuruta, Kouichi Haraguchi, Masato Okamoto, Haruo Sugiyama & Shigeo Koido. (2019) Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines. Human Vaccines & Immunotherapeutics 15:2, pages 397-406.
Read now
Matthew E Eagles, Farshad Nassiri, Jetan H Badhiwala, Suganth Suppiah, Saleh A Almenawer, Gelareh Zadeh & Kenneth D Aldape. (2018) Dendritic cell vaccines for high-grade gliomas. Therapeutics and Clinical Risk Management 14, pages 1299-1313.
Read now
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas & Evelyne Beraud. (2018) Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. OncoImmunology 7:12.
Read now
Mareike Grees, Adi Sharbi-Yunger, Christos Evangelou, Daniel Baumann, Gal Cafri, Esther Tzehoval, Stefan B. Eichmüller, Rienk Offringa, Jochen Utikal, Lea Eisenbach & Viktor Umansky. (2018) Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. OncoImmunology 7:7.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now

Articles from other publishers (55)

Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, Natasza Michalska, Sara Paszkowska, Adrianna Napierała & Andrzej Mackiewicz. (2023) Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review. Cells 12:17, pages 2159.
Crossref
Shay Sharon, Narmeen Daher-Ghanem, Deema Zaid, Michael J. Gough & Nataly Kravchenko-Balasha. (2023) The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer. Frontiers in Oral Health 4.
Crossref
Simon Hawlina, Robert Zorec & Helena H. Chowdhury. (2023) Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer. Life 13:7, pages 1498.
Crossref
Saleh Alrhmoun & Sergey Sennikov. (2022) The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions. Cancers 14:24, pages 6173.
Crossref
Dmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova & Daniel Smrz. (2022) LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 14:12, pages 2747.
Crossref
Santiago Moragon, Cristina Hernando, Maria Teresa Martinez-Martinez, Marta Tapia, Belen Ortega-Morillo, Ana Lluch, Begoña Bermejo & Juan Miguel Cejalvo. (2022) Immunological Landscape of HER-2 Positive Breast Cancer. Cancers 14:13, pages 3167.
Crossref
Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Shinji Morisaki, Yusuke Nakamura & Hideya Onishi. (2022) Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy. Cancers 14:10, pages 2438.
Crossref
Lanlin Zhang, Jiangyuan Du, Qian Song, Chufan Zhang & Xianghua Wu. (2022) A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity. Journal of Immunology Research 2022, pages 1-17.
Crossref
Bin Wang, Hanfei Guo, Haiyang Xu, Yong Chen, Gang Zhao & Hongquan Yu. (2022) The Role of Graphene Oxide Nanocarriers in Treating Gliomas. Frontiers in Oncology 12.
Crossref
N. B. Zakharova, A. N. Ponukalin, M. L. Chekhonatskaya, A. Y. Korolev & Y. M. Komyagina. (2022) Biomarkers of tumor microenvironment of malignant neoplasms of kidneys, urinary bladder, and prostate gland (literature review). Medical alphabet:41, pages 41-46.
Crossref
K.E. Boeva, T.V. Makhorina, G.V. Malyshkina & A.V. Semenov. (2022) Cytokine response and possibilities of virus evidence from immune response on the example of exposure to l2 peptide of human papilloma virus type 16. Laboratornaya sluzhba 11:4, pages 16.
Crossref
Mona Yazdani, Amin Reza Nikpoor, Zahra Gholizadeh, Nema Mohamadian Roshan, Alexander Seifalian, Mahmoud Reza Jaafari & Ali Badiee. (2021) Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model. International Immunopharmacology 98, pages 107833.
Crossref
Daniela Lisini, Sara Lettieri, Sara Nava, Giulia Accordino, Simona Frigerio, Chandra Bortolotto, Andrea Lancia, Andrea Riccardo Filippi, Francesco Agustoni, Laura Pandolfi, Davide Piloni, Patrizia Comoli, Angelo Guido Corsico & Giulia Maria Stella. (2021) Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach. International Journal of Molecular Sciences 22:16, pages 9014.
Crossref
David A. Bernal-Estévez, Mauren A. Ortíz Barbosa, Paola Ortíz-Montero, Claudia Cifuentes, Ramiro Sánchez & Carlos A. Parra-López. (2021) Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial. Frontiers in Immunology 12.
Crossref
Waqas Azeem, Ragnhild Maukon Bakke, Benjamin Gabriel, Silke Appel, Anne Margrete Øyan & Karl-Henning Kalland. (2021) Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells. Biomedicines 9:8, pages 949.
Crossref
Savannah E. Est-Witte, Natalie K. Livingston, Mary O. Omotoso, Jordan J. Green & Jonathan P. Schneck. (2021) Nanoparticles for generating antigen-specific T cells for immunotherapy. Seminars in Immunology 56, pages 101541.
Crossref
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, Marilena V. Iorio & Alessandra Cataldo. (2021) Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers 13:15, pages 3691.
Crossref
Grace H. Attrill, Peter M. Ferguson, Umaimainthan Palendira, Georgina V. Long, James S. Wilmott & Richard A. Scolyer. (2020) The tumour immune landscape and its implications in cutaneous melanoma. Pigment Cell & Melanoma Research 34:3, pages 529-549.
Crossref
Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill Comeau & Seetharama Jois. (2021) Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. International Journal of Molecular Sciences 22:2, pages 779.
Crossref
Kevin Wijanarko, Meijun Wang & Kwan T. Chow. 2020. Detection Methods in Precision Medicine. Detection Methods in Precision Medicine 303 344 .
Maarten K. Nijen Twilhaar, Lucas Czentner, Joanna Grabowska, Alsya J. Affandi, Chun Yin Jerry Lau, Katarzyna Olesek, Hakan Kalay, Cornelus F. van Nostrum, Yvette van Kooyk, Gert Storm & Joke M.M. den Haan. (2020) Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages. Pharmaceutics 12:12, pages 1138.
Crossref
Mina Shahnazari, Pouria Samadi, Mona Pourjafar & Akram Jalali. (2020) Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 88, pages 106944.
Crossref
Meng Zhang, Yanmei Shi, Yujuan Zhang, Yifan Wang, Faizah Alotaibi, Li Qiu, Hongmei Wang, Shanshan Peng, Yanling Liu, Qing Li, Dian Gao, Zhigang Wang, Keng Yuan, Fang-fang Dou, James Koropatnick, Jianping Xiong & Weiping Min. (2020) miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. Cancer Immunology, Immunotherapy 69:6, pages 951-967.
Crossref
María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro & Jessica Dal Col. (2020) Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity. Pharmaceutics 12:3, pages 256.
Crossref
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin & Andrey A. ZamyatninJr.Jr.. (2020) Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting. Cancers 12:3, pages 590.
Crossref
E. A. Ustyugova, M. V. Savkina, A. A. Goryaev, V. P. Bondarev, V. A. Merkulov & E. V. Melnikova. (2019) The Current Use of Biomedical Cell Products for Cancer Treatment. BIOpreparations. Prevention, Diagnosis, Treatment 19:4, pages 206-214.
Crossref
A. A. Borunova, G. Z. Chkadua, T. N. Zabotina, Z. G. Kadagidze, O. V. Korotkova, A. I. Chertkova, D. V. Tabakov, E. N. Zakharova, E. K. Shoua, N. N. Petenko, L. V. Demidov & I. N. Mikhailova. (2019) INCREASE IN NKT CELLS – A MARKER OF EARLY PROGRESSING AT ADJUVANTVACCINOTHERAPY OF PATIENTS WITH A METASTATIC MELANOMA OF SKIN. Russian Journal of Biotherapy 18:4, pages 82-89.
Crossref
Peter H. Liu & Samuel Sidi. (2019) Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?. Frontiers in Oncology 9.
Crossref
María Julia Lamberti, Fátima María Mentucci, Emiliano Roselli, Paula Araya, Viviana Alicia Rivarola, Natalia Belén Rumie Vittar & Mariana Maccioni. (2019) Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation. Frontiers in Immunology 10.
Crossref
Jitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova & Radek Spisek. (2019) Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications. Frontiers in Immunology 10.
Crossref
Gessani & Belardelli. (2019) Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells. Cancers 11:10, pages 1491.
Crossref
Luciano Castiello, Eleonora Aricò, Giuseppina D'Agostino, Laura Santodonato & Filippo Belardelli. (2019) In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?. Frontiers in Immunology 10.
Crossref
Kyung-Min Cho, Myun Soo Kim, Hak-Jun Jung, Eui-Ju Choi & Tae Sung Kim. (2019) Mst1-Deficiency Induces Hyperactivation of Monocyte-Derived Dendritic Cells via Akt1/c-myc Pathway. Frontiers in Immunology 10.
Crossref
Aishwarya Joshi, Nikunj Tandel, Priyanka Tyagi, Sarat K Dalai, Prakash S Bisen & Rajeev K Tyagi. (2019) RNA-loaded dendritic cells: more than a tour de force in cancer therapeutics . Immunotherapy 11:13, pages 1129-1147.
Crossref
M. Christina Cox, Luciano Castiello, Mauro Mattei, Laura Santodonato, Giuseppina D'Agostino, Elena Muraro, Debora Martorelli, Caterina Lapenta, Arianna Di Napoli, Francesca Di Landro, Michela Cangemi, Antonio Pavan, Paolo Castaldo, Stefan Hohaus, Simona Donati, Enrica Montefiore, Cinzia Berdini, Davide Carlei, Domenica M. Monque, Luigi Ruco, Daniela Prosperi, Agostino Tafuri, Francesca Spadaro, Paola Sestili, Massimo Spada, Riccardo Dolcetti, Stefano M. Santini, Carmela Rozera, Eleonora Aricò, Imerio Capone & Filippo Belardelli. (2019) Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial. Clinical Cancer Research 25:17, pages 5231-5241.
Crossref
Zenan Wang, Zhan Wang, Binghao Li, Shengdong Wang, Tao Chen & Zhaoming Ye. (2019) Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma. Frontiers in Immunology 10.
Crossref
Guibin Pang, Shulei Zhang, Xiapeng Zhou, Huan Yu, Yanxian Wu, Tianyan Jiang, Xihui Zhang, Fujun Wang, Yangyun Wang & Leshuai W Zhang. (2019) Immunoactive polysaccharide functionalized gold nanocomposites promote dendritic cell stimulation and antitumor effects. Nanomedicine 14:10, pages 1291-1306.
Crossref
Beatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquie, Philippe O. Gannon & Lana E. Kandalaft. (2019) Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results. Frontiers in Immunology 10.
Crossref
Dieke van Dinther, Miguel Lopez Venegas, Henrike Veninga, Katarzyna Olesek, Leoni Hoogterp, Mirjam Revet, Martino Ambrosini, Hakan Kalay, Johannes Stöckl, Yvette van Kooyk & Joke den Haan. (2019) Activation of CD8+ T Cell Responses after Melanoma Antigen Targeting to CD169+ Antigen Presenting Cells in Mice and Humans. Cancers 11:2, pages 183.
Crossref
Huaguo Zheng, Lanlan Liu, Han Zhang, Fangming Kan, Shuo Wang, Yang Li, Huaqin Tian & Songdong Meng. (2019) Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses. PLOS ONE 14:1, pages e0211490.
Crossref
Timothée Chanier & Patrick Chames. (2019) Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer. Antibodies 8:1, pages 13.
Crossref
Ananda Mookerjee, Michele Graciotti & Lana E. Kandalaft. (2019) IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine. Cancers 11:1, pages 40.
Crossref
Miquel Lozano, Joan Cid, Daniel Benitez-Ribas & Manel Juan Otero. (2019) Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies. European Oncology & Haematology 15:1, pages 22.
Crossref
Wen Zhang, Xu Lu, Peilin Cui, Chunmei Piao, Man Xiao, Xuesong Liu, Yue Wang, Xuan Wu, Jingwei Liu & Lin Yang. (2018) Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer. Cancer Immunology, Immunotherapy 68:1, pages 121-130.
Crossref
R. A. Belderbos, R. Cornelissen & J. G. J. V. Aerts. 2019. Mesothelioma. Mesothelioma 271 280 .
Tonke K. Raaijmakers & Marleen Ansems. (2018) Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands. Cancer Immunology, Immunotherapy 67:11, pages 1789-1796.
Crossref
Nina Tel-Karthaus, Esther D. Kers-Rebel, Maaike W. Looman, Hiroshi Ichinose, Carlie J. de Vries & Marleen Ansems. (2018) Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function. Frontiers in Immunology 9.
Crossref
Ananda Mookerjee, Michele Graciotti & Lana Kandalaft. (2018) A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model. BioImpacts 8:3, pages 211-221.
Crossref
Mansi Saxena, Sreekumar Balan, Vladimir Roudko & Nina Bhardwaj. (2018) Towards superior dendritic-cell vaccines for cancer therapy. Nature Biomedical Engineering 2:6, pages 341-346.
Crossref
Annelisa M. Cornel, Niek P. van Til, Jaap Jan Boelens & Stefan Nierkens. (2018) Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies. Frontiers in Immunology 9.
Crossref
Maarten Versteven, Johan M. J. Van den Bergh, Elly Marcq, Evelien L. J. Smits, Viggo F. I. Van Tendeloo, Willemijn Hobo & Eva Lion. (2018) Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology 9.
Crossref
Kristian M. Hargadon. (2017) Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma. Frontiers in Immunology 8.
Crossref
Abhishek D. Garg & Patrizia Agostinis. (2017) Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. Immunological Reviews 280:1, pages 126-148.
Crossref
Shuang Li, Jing Wu, Shan Zhu, Yong-Jun Liu & Jingtao Chen. (2017) Disease-Associated Plasmacytoid Dendritic Cells. Frontiers in Immunology 8.
Crossref
Claudia Penafuerte, Luis Alberto Perez-Quintero, Valerie Vinette, Teri Hatzihristidis & Michel L. Tremblay. 2017. Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity. Emerging Concepts Targeting Immune Checkpoints in Cancer and Autoimmunity 191 214 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.